{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:23:00Z","timestamp":1791051780637,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,10,16]],"date-time":"2009-10-16T00:00:00Z","timestamp":1255651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s10549-009-0577-9","type":"journal-article","created":{"date-parts":[[2009,10,15]],"date-time":"2009-10-15T07:44:33Z","timestamp":1255592673000},"page":"367-377","source":"Crossref","is-referenced-by-count":114,"title":["Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients"],"prefix":"10.1007","volume":"119","author":[{"given":"K.","family":"Hancke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Grubeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kreienberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,16]]},"reference":[{"key":"577_CR1","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1038\/sj.onc.1206824","volume":"22","author":"M Pignatelli","year":"2003","unstructured":"Pignatelli M, Cocca C, Santos A, Perez-Castillo A (2003) Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor gamma in the MCF-7 breast cancer cell line. Oncogene 22:5446\u20135450","journal-title":"Oncogene"},{"key":"577_CR2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.33549\/physiolres.930848","volume":"55","author":"D Housa","year":"2006","unstructured":"Housa D, Housova J, Vernerova Z, Haluzik M (2006) Adipocytokines and cancer. Physiol Res 55:233\u2013244","journal-title":"Physiol Res"},{"key":"577_CR3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1677\/erc.1.00729","volume":"13","author":"A Lorincz","year":"2006","unstructured":"Lorincz A, Sukumar S (2006) Molecular links between obesity and breast cancer. Endocr Relat Cancer 13:279\u2013292","journal-title":"Endocr Relat Cancer"},{"key":"577_CR4","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ijc.20315","volume":"111","author":"PH Lahmann","year":"2004","unstructured":"Lahmann PH, Hoffmann K, Allen N et al (2004) Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 111:762\u2013771","journal-title":"Int J Cancer"},{"key":"577_CR5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/aje\/152.6.514","volume":"152","author":"PA Brandt van den","year":"2000","unstructured":"van den Brandt PA, Spiegelman D, Yaun SS et al (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152:514\u2013527","journal-title":"Am J Epidemiol"},{"key":"577_CR6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1467-789X.2004.00142.x","volume":"5","author":"D Rose","year":"2004","unstructured":"Rose D, Komninou D, Stephenson G (2004) Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 5:153\u2013165","journal-title":"Obes Rev"},{"key":"577_CR7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1158\/1055-9965.2.14.1","volume":"14","author":"O Fletcher","year":"2005","unstructured":"Fletcher O, Gibson L, Johnson N, Altmann DR, Holly JMP, Ashworth A, Peto J, Silva IDS (2005) Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 14:2\u201319","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"577_CR8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1677\/ERC-06-0068","volume":"14","author":"L Vona-Davis","year":"2007","unstructured":"Vona-Davis L, Rose DP (2007) Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Rel Cancer 14:189\u2013206","journal-title":"Endocr Rel Cancer"},{"key":"577_CR9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1530\/eje.0.1350649","volume":"135","author":"F Rohner-Jeanrenaud","year":"1996","unstructured":"Rohner-Jeanrenaud F, Jeanrenaud B (1996) The discovery of leptin and its impact in the understanding of obesity. Eur J Endocrinol\/European Federation of Endocrine Societies 135:649\u2013650","journal-title":"Eur J Endocrinol\/European Federation of Endocrine Societies"},{"key":"577_CR10","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1158\/1078-0432.CCR-03-0749","volume":"10","author":"M Ishikawa","year":"2004","unstructured":"Ishikawa M, Kitayama J, Nagawa H (2004) Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10:4325\u20134331","journal-title":"Clin Cancer Res"},{"key":"577_CR11","first-page":"5699","volume":"9","author":"Y Miyoshi","year":"2003","unstructured":"Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S (2003) Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 9:5699\u20135704","journal-title":"Clin Cancer Res"},{"key":"577_CR12","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jc.2003-031804","volume":"89","author":"C Mantzoros","year":"2004","unstructured":"Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, Papadiamantis Y, Markopoulos C, Spanos E, Chrousos G, Trichopoulos D (2004) Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89:1102\u20131107","journal-title":"J Clin Endocrinol Metab"},{"key":"577_CR13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/EJE-07-0102","volume":"157","author":"M M\u00f6hlig","year":"2007","unstructured":"M\u00f6hlig M, Weickert MO, Ghadamgadai E, Machlitt A, Pf\u00fcller B, Arafat AM, Pfeiffer AFH, Sch\u00f6fl C (2007) Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women. Eur J Endocrinol\/European Federation of Endocrine Societies 157:195\u2013200","journal-title":"Eur J Endocrinol\/European Federation of Endocrine Societies"},{"key":"577_CR14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00041433-200204000-00005","volume":"13","author":"JB Boord","year":"2002","unstructured":"Boord JB, Fazio S, Linton MF (2002) Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol 13:141\u2013147","journal-title":"Curr Opin Lipidol"},{"key":"577_CR15","first-page":"133","volume":"5","author":"R Hammamieh","year":"2005","unstructured":"Hammamieh R, Chakraborty N, Barmada M, Das R, Jett M (2005) Expression patterns of fatty acid binding proteins in breast cancer cells. J Exp Therap Oncol 5:133\u2013143","journal-title":"J Exp Therap Oncol"},{"key":"577_CR16","unstructured":"Li H, Lu Q, Dong L, Xue H, Zhou H, Yang H (2007) Expression of fatty acid binding protein in human breast cancer tissues. Chin J Cell Mol Immunol 23:312\u2013316. (in Chinese by Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi)"},{"key":"577_CR17","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/oxfordjournals.aje.a008803","volume":"143","author":"CA Swanson","year":"1996","unstructured":"Swanson CA, Coates RJ, Schoenberg JB, Malone KE, Gammon MD, Stanford JL, Shorr IJ, Potischman NA, Brinton LA (1996) Body size and breast cancer risk among women under age 45\u00a0years. Am J Epidemiol 143:698\u2013706","journal-title":"Am J Epidemiol"},{"key":"577_CR18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1097-0215(19960717)67:2<181::AID-IJC5>3.0.CO;2-P","volume":"67","author":"S Franceschi","year":"1996","unstructured":"Franceschi S, Favero A, La Vecchia C, Bar\u00f3n AE, Negri E, Dal Maso L, Giacosa A, Montella M, Conti E, Amadori D (1996) Body size indices and breast cancer risk before and after menopause. Int J Cancer 67:181\u2013186","journal-title":"Int J Cancer"},{"key":"577_CR19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1023\/A:1018479020716","volume":"8","author":"PA Brandt van den","year":"1997","unstructured":"van den Brandt PA, Dirx MJ, Ronckers CM, van den Hoogen P, Goldbohm RA (1997) Height, weight change, and postmenopausal breast cancer risk: the Netherlands Cohort Study. Cancer Causes Control 8:39\u201347","journal-title":"Cancer Causes Control"},{"key":"577_CR20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1471-2407-8-278","volume":"8","author":"A Montazeri","year":"2008","unstructured":"Montazeri A, Sadighi J, Farzadi F, Maftoon F, Vahdaninia M, Ansari M, Sajadian A, Ebrahimi M, Haghighat S, Harirchi I (2008) Weight, height, body mass index and risk of breast cancer in postmenopausal women: a case\u2013control study. BMC Cancer 8:278","journal-title":"BMC Cancer"},{"key":"577_CR21","doi-asserted-by":"crossref","unstructured":"Trentham-Dietz A, Newcomb PA, Egan KM, Titus-Ernstoff L, Baron JA, Storer BE, Stampfer M, Willett WC (2000) Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control 11:533\u2013542","DOI":"10.1023\/A:1008961931534"},{"key":"577_CR22","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/00029330-200709020-00009","volume":"120","author":"W Hou","year":"2007","unstructured":"Hou W, Xu Y, Yu T, Zhang L, Zhang W, Fu C, Sun Y, Wu Q, Chen L (2007) Adipocytokines and breast cancer risk. Chin Med J 120:1592\u20131596","journal-title":"Chin Med J"},{"issue":"9","key":"577_CR23","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/sj.bjc.6605025","volume":"100","author":"L Rosenberg","year":"2009","unstructured":"Rosenberg L, Czene K, Hall P (2009) Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy. Br J Cancer 100(9):1486\u20131491","journal-title":"Br J Cancer"},{"key":"577_CR24","first-page":"1706","volume":"7","author":"R Das","year":"2001","unstructured":"Das R, Hammamieh R, Neill R, Melhem M, Jett M (2001) Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues. Clin Cancer Res 7:1706\u20131715","journal-title":"Clin Cancer Res"},{"key":"577_CR25","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1074\/mcp.M500017-MCP200","volume":"4","author":"G Ohlsson","year":"2005","unstructured":"Ohlsson G, Moreira JMA, Gromov P, Sauter G, Celis JE (2005) Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas. Mol Cell Proteomics 4:570\u2013581","journal-title":"Mol Cell Proteomics"},{"key":"577_CR26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1373\/clinchem.2005.062463","volume":"52","author":"A Xu","year":"2006","unstructured":"Xu A, Wang Y, Xu JY, Stejskal D, Tam S, Zhang J, Wat NMS, Wong WK, Lam KSL (2006) Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 52:405\u2013413","journal-title":"Clin Chem"},{"key":"577_CR27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2362.2006.01696.x","volume":"36","author":"D Stejskal","year":"2006","unstructured":"Stejskal D, Karpisek M (2006) Adipocyte fatty acid binding protein in a Caucasian population: a new marker of metabolic syndrome? Eur J Clin Investig 36:621\u2013625","journal-title":"Eur J Clin Investig"},{"key":"577_CR28","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/ATVBAHA.107.146274","volume":"27","author":"DCY Yeung","year":"2007","unstructured":"Yeung DCY, Xu A, Cheung CWS, Wat NMS, Yau MH, Fong CHY, Chau MT, Lam KSL (2007) Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol 27:1796\u20131802","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"577_CR29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2337\/dc08-1379","volume":"32","author":"JH Koh","year":"2009","unstructured":"Koh JH, Shin YG, Nam SM, Lee MY, Chung CH, Shin JY (2009) Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients. Diabetes Care 32:147\u2013152","journal-title":"Diabetes Care"},{"key":"577_CR30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1023\/A:1008903727238","volume":"11","author":"E Petridou","year":"2000","unstructured":"Petridou E, Papadiamantis Y, Markopoulos C, Spanos E, Dessypris N, Trichopoulos D (2000) Leptin and insulin growth factor I in relation to breast cancer (Greece). Cancer Causes Control 11:383\u2013388","journal-title":"Cancer Causes Control"},{"key":"577_CR31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/jjco\/hye097","volume":"31","author":"A Ozet","year":"2001","unstructured":"Ozet A, Arpaci F, Yilmaz MI, Ayta H, Ozturk B, Komurcu S, Yavuz AA, Tezcan Y, Acikel C (2001) Effects of tamoxifen on the serum leptin level in patients with breast cancer. Jpn J Clin Oncol 31:424\u2013427","journal-title":"Jpn J Clin Oncol"},{"key":"577_CR32","first-page":"41","volume":"50","author":"U Coskun","year":"2003","unstructured":"Coskun U, G\u00fcnel N, Toruner FB, Sancak B, Onuk E, Bayram O, Cengiz O, Yilmaz E, Elbeg S, Ozkan S (2003) Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer. Neoplasma 50:41\u201346","journal-title":"Neoplasma"},{"key":"577_CR33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1055\/s-2004-814490","volume":"36","author":"ER Sauter","year":"2004","unstructured":"Sauter ER, Garofalo C, Hewett J, Hewett JE, Morelli C, Surmacz E (2004) Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer. Horm Metab Res 36:336\u2013340","journal-title":"Horm Metab Res"},{"key":"577_CR34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2005.05.041","volume":"237","author":"H Woo","year":"2006","unstructured":"Woo H, Park H, Ki C, Park YL, Bae WG (2006) Relationships among serum leptin, leptin receptor gene polymorphisms, and breast cancer in Korea. Cancer Lett 237:137\u2013142","journal-title":"Cancer Lett"},{"key":"577_CR35","first-page":"1529","volume":"24","author":"L Tessitore","year":"2004","unstructured":"Tessitore L, Vizio B, Pesola D, Cecchini F, Mussa A, Argiles JM, Benedetto C (2004) Adipocyte expression and circulating levels of leptin increase in both gynaecological and breast cancer patients. Int J Oncol 24:1529\u20131535","journal-title":"Int J Oncol"},{"key":"577_CR36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2005.05.047","volume":"237","author":"D Chen","year":"2006","unstructured":"Chen D, Chung Y, Yeh Y, Chaung H, Kuo F, Fu O, Chen H, Hou M, Yuan SF (2006) Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237:109\u2013114","journal-title":"Cancer Lett"},{"key":"577_CR37","first-page":"421","volume":"5","author":"L Tessitore","year":"2000","unstructured":"Tessitore L, Vizio B, Jenkins O, De Stefano I, Ritossa C, Argiles JM, Benedetto C, Mussa A (2000) Leptin expression in colorectal and breast cancer patients. Int J Mol Med 5:421\u2013426","journal-title":"Int J Mol Med"},{"key":"577_CR38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1385\/ENDO:26:1:019","volume":"26","author":"C Han","year":"2005","unstructured":"Han C, Zhang H, Du L, Liu X, Jing J, Zhao X, Yang X, Tian B (2005) Serum levels of leptin, insulin, and lipids in relation to breast cancer in china. Endocrine 26:19\u201324","journal-title":"Endocrine"},{"key":"577_CR39","first-page":"269","volume":"52","author":"RM Cento","year":"1999","unstructured":"Cento RM, Proto C, Spada RS, Napolitano V, Ciampelli M, Cucinelli F, Lanzone A (1999) Leptin levels in menopause: effect of estrogen replacement therapy. Horm Res 52:269\u2013273","journal-title":"Horm Res"},{"key":"577_CR40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2114\/jpa.21.105","volume":"21","author":"H Hayase","year":"2002","unstructured":"Hayase H, Nomura S, Abe T, Izawa T (2002) Relation between fat distributions and several plasma adipocytokines after exercise training in premenopausal and postmenopausal women. J Physiol Anthropol Appl Hum Sci 21:105\u2013113","journal-title":"J Physiol Anthropol Appl Hum Sci"},{"key":"577_CR41","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1530\/eje.0.1390528","volume":"139","author":"MG Riad-Gabriel","year":"1998","unstructured":"Riad-Gabriel MG, Jinagouda SD, Sharma A, Boyadjian R, Saad MF (1998) Changes in plasma leptin during the menstrual cycle. Eur J Endocrinol\/European Federation of Endocrine Societies 139:528\u2013531","journal-title":"Eur J Endocrinol\/European Federation of Endocrine Societies"},{"key":"577_CR42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1530\/eje.0.1420174","volume":"142","author":"F Cella","year":"2000","unstructured":"Cella F, Giordano G, Cordera R (2000) Serum leptin concentrations during the menstrual cycle in normal-weight women: effects of an oral triphasic estrogen-progestin medication. Eur J Endocrinol\/European Federation of Endocrine Societies 142:174\u2013178","journal-title":"Eur J Endocrinol\/European Federation of Endocrine Societies"},{"key":"577_CR43","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.fertnstert.2003.06.020","volume":"81","author":"F Geisth\u00f6vel","year":"2004","unstructured":"Geisth\u00f6vel F, Jochmann N, Widjaja A, Horn R, Brabant G (2004) Serum pattern of circulating free leptin, bound leptin, and soluble leptin receptor in the physiological menstrual cycle. Fertil Steril 81:398\u2013402","journal-title":"Fertil Steril"},{"key":"577_CR44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/B:BREA.0000036782.11945.d7","volume":"86","author":"P Stattin","year":"2004","unstructured":"Stattin P, S\u00f6derberg S, Biessy C, Lenner P, Hallmans G, Kaaks R, Olsson T (2004) Plasma leptin and breast cancer risk: a prospective study in northern Sweden. Breast Cancer Res Treat 86:191\u2013196","journal-title":"Breast Cancer Res Treat"},{"key":"577_CR45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000063433","volume":"54","author":"M Gr\u00f6schl","year":"2000","unstructured":"Gr\u00f6schl M, Wagner R, D\u00f6rr HG, Blum W, Rascher W, D\u00f6tsch J (2000) Variability of leptin values measured from different sample matrices. Horm Res 54:26\u201331","journal-title":"Horm Res"},{"key":"577_CR46","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.annepidem.2003.10.006","volume":"14","author":"MW Steffes","year":"2004","unstructured":"Steffes MW, Gross MD, Schreiner PJ, Yu X, Hilner JE, Gingerich R, Jacobs DR (2004) Serum adiponectin in young adults\u2014interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study. Ann Epidemiol 14:492\u2013498","journal-title":"Ann Epidemiol"},{"key":"577_CR47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2741\/s30","volume":"1","author":"MP Cleary","year":"2009","unstructured":"Cleary MP, Ray A, Rogozina OP, Dogan S, Grossmann ME (2009) Targeting the adiponectin: leptin ratio for postmenopausal breast cancer prevention. Front Biosci (schol Ed) 1:329\u2013357","journal-title":"Front Biosci (schol Ed)"},{"key":"577_CR48","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/annonc\/mdh222","volume":"15","author":"G Berclaz","year":"2004","unstructured":"Berclaz G, Li S, Price KN, Coates AS, Castiglione-Gertsch M, Rudenstam C, Holmberg SB, Lindtner J, Erien D, Collins J, Snyder R, Th\u00fcrlimann B, Fey MF, Mendiola C, Werner ID, Simoncini E, Crivellari D, Gelber RD, Goldhirsch A (2004) Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol 15:875\u2013884","journal-title":"Ann Oncol"},{"key":"577_CR49","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. New Engl J Med 348:1625\u20131638","journal-title":"New Engl J Med"},{"key":"577_CR50","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1200\/JCO.2005.02.048","volume":"23","author":"PJ Goodwin","year":"2005","unstructured":"Goodwin PJ, Ennis M, Fantus IG, Pritchard KI, Trudeau ME, Koo J, Hood N (2005) Is leptin a mediator of adverse prognostic effects of obesity in breast cancer? J Clin Oncol 23:6037\u20136042","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0577-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-009-0577-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0577-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T05:22:59Z","timestamp":1685164979000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-009-0577-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,16]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["577"],"URL":"https:\/\/doi.org\/10.1007\/s10549-009-0577-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,16]]}}}